Longeveron Shares Are Trading Higher After the Company Announced That the FDA Granted Fast Track Designation to Lomecel-B for the Treatment of Mild Alzheimer's Disease
長生隆公司宣佈,Lomecel-b治療輕度阿爾茨海默病獲得FDA提速審批認定後,股票價格上漲。
Longeveron Shares Are Trading Higher After the Company Announced That the FDA Granted Fast Track Designation to Lomecel-B for the Treatment of Mild Alzheimer's Disease
長生隆公司宣佈,Lomecel-b治療輕度阿爾茨海默病獲得FDA提速審批認定後,股票價格上漲。
使用瀏覽器的分享功能,分享給你的好友吧